Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1120320230090040137
Osteoporosis and Sarcopenia
2023 Volume.9 No. 4 p.137 ~ p.141
Effect of romosozumab in premenopausal women with severe osteoporosis and anorexia nervosa
Kazuki Fujimoto

Narumi Maki
Daisuke Hashiba
Toshifumi Maeyama
Ryosuke Nakagawa
Hajime Arai
Seiji Ohtori
Abstract
Objectives: This study aims to investigate the effects of romosozumab on bone mineral density (BMD) and bone metabolism.

Methods: In this retrospective case series, romosozumab was administered to 5 premenopausal female patients with osteoporosis and anorexia nervosa with fragility fractures. BMD and bone turnover marker changes were investigated at 6 months and 1 year after administering romosozumab.

Results: BMD increased and high-turnover bone metabolism decreased 6 months and 1 year after administering romosozumab.

Conclusions: Romosozumab is useful for treating osteoporosis in patients with anorexia nervosa.
KEYWORD
Anorexia nervosa, Secondary osteoporosis, Anti-sclerostin antibody, Bone metabolism
FullTexts / Linksout information
Listed journal information